<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Technology | Holland Stem Cells</title>
    <!-- Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600&family=Outfit:wght@700;800&display=swap"
        rel="stylesheet">
    <!-- Font Awesome -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <!-- Custom CSS -->
    <link rel="stylesheet" href="css/styles.css">
</head>

<body>

    <!-- Header -->
    <header>
        <div class="container">
            <nav>
                <div class="logo">
                    <a href="https://hollandstemcells.netlify.app/"
                        style="display: flex; align-items: center; gap: 0.5rem; color: white;">
                        <i class="fa-solid fa-dna"></i>
                        Holland Stem Cells
                    </a>
                </div>
                <!-- Mobile Menu Button -->
                <div class="menu-btn" id="mobile-menu-btn">
                    <span></span>
                    <span></span>
                    <span></span>
                </div>
                <ul class="nav-links">
                    <li><a href="https://hollandstemcells.netlify.app/#home">Home</a></li>
                    <li><a href="https://hollandstemcells.netlify.app/#technology">Technology</a></li>
                    <li><a href="https://hollandstemcells.netlify.app/#standards">Standards</a></li>
                    <li><a href="https://hollandstemcells.netlify.app/#process">Process</a></li>
                    <li><a href="https://hollandstemcells.netlify.app/privacy-policy">Privacy</a></li>
                    <li><a href="https://hollandstemcells.netlify.app/news">News</a></li>
                    <li><a href="https://hollandstemcells.netlify.app/#contact" class="btn btn-primary"
                            style="padding: 0.5rem 1.5rem; margin-left: 1rem;">Contact Us</a></li>
                </ul>
            </nav>
        </div>
    </header>

    <!-- Page Header -->
    <section class="hero hero-inner" style="min-height: 40vh; height: auto; padding: 120px 0 60px;">
        <div class="container">
            <div class="hero-content">
                <h1>Our Stem Cell Treatment Technologies</h1>
                <p>Advanced protocols for maximal quality and safety.</p>
            </div>
        </div>
    </section>

    <!-- Main Content -->
    <section class="section-padding" style="background: var(--color-light);">
        <div class="container">
            <div style="max-width: 900px; margin: 0 auto;">

                <div class="about-text" style="margin-bottom: 3rem;">
                    <p>The success of stem-cell-based therapies begins with the adoption of cell processing and
                        manufacturing methods that promote maximal quality and safety of the cells to be used.</p>

                    <p>Our medical and scientific research team has well-developed autologous adult stem cell
                        technologies, which are currently applied in our 167 medical centers in 35 countries globally to
                        treat many diseases. In compliance with the US FDA and the MOH regulations, the training covers
                        the following three advanced innovative clinical technologies in regenerative medicine and
                        investigational stem cell research and treatment methods:</p>
                </div>

                <div
                    style="background: white; padding: 2rem; border-radius: 8px; box-shadow: 0 4px 20px rgba(0,0,0,0.05); margin-bottom: 2rem;">
                    <h3 style="color: var(--color-primary); margin-bottom: 1.5rem;">Autologous Adult Stem Cell
                        Technologies</h3>
                    <ul class="about-list">
                        <li><i class="fa-solid fa-check-circle" style="color: var(--color-secondary);"></i> Autologous
                            adult adipose-derived SC Treatment</li>
                        <li><i class="fa-solid fa-check-circle" style="color: var(--color-secondary);"></i> Autologous
                            Bone-Marrow-derived SC Treatment</li>
                        <li><i class="fa-solid fa-check-circle" style="color: var(--color-secondary);"></i> Autologous
                            adult Platelet-Rich-Plasma isolation and processing</li>
                    </ul>
                </div>

                <!-- Nature's Blueprint for Healing -->
                <div class="about-grid fade-in"
                    style="margin: 3rem 0; align-items: center; background: #eef2f7; padding: 2.5rem; border-radius: 12px; border-left: 5px solid var(--color-secondary);">
                    <div class="about-image">
                        <img src="images/lizard-regeneration.jpg.png"
                            alt="Lizard tail regeneration - Nature's proof of autologous stem cells"
                            style="border-radius: 8px; box-shadow: var(--shadow-soft);">
                    </div>
                    <div class="about-text">
                        <h2 style="color: var(--color-primary); margin-bottom: 1rem; font-size: 1.8rem;">Nature's
                            Blueprint for Healing</h2>
                        <p
                            style="font-size: 1.1rem; line-height: 1.6; color: var(--color-text-dark); font-style: italic;">
                            "In nature, regeneration is a biological reality. Just as certain species regrow lost limbs
                            or tails using their own autologous stem cells, our therapies aim to activate the human
                            body's innate potential to repair and restore itself."
                        </p>
                    </div>
                </div>

                <div
                    style="background: white; padding: 2rem; border-radius: 8px; box-shadow: 0 4px 20px rgba(0,0,0,0.05); margin-bottom: 2rem;">
                    <h3 style="color: var(--color-primary); margin-bottom: 1.5rem;">Allogeneic Adult Stem Cells sources
                    </h3>
                    <p style="margin-bottom: 1rem;">Allogeneic adult stem cells (from a donor) may be used from the
                        following sources, under our approved procedural protocols and per applicable laws in each
                        country:</p>
                    <ul class="about-list" style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> Umbilical cord
                            blood UCB</li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> Placental
                            blood and tissue</li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> Wharton's
                            Jelly Mesenchymal Stem Cells</li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> Peripheral
                            fluid (in the uterine sac)</li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> Venous Blood
                        </li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> Exosomes</li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> CAR-T Cells
                        </li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> NK-Cells</li>
                        <li><i class="fa-solid fa-dot-circle" style="color: var(--color-secondary);"></i> Peptides</li>
                    </ul>
                </div>

                <div class="about-text" style="margin-bottom: 3rem;">
                    <p>Studies on this therapy method demonstrate a positive effect, for example, even in cases of
                        severe osteoarthritis, wound healing disorders, scar treatment, injuries to the muscles,
                        tendons, and ligaments while also carrying a low risk of unwanted side effects.</p>
                </div>

                <div
                    style="background: #eef2f7; padding: 2rem; border-left: 4px solid var(--color-primary); border-radius: 0 8px 8px 0;">
                    <h4 style="color: var(--color-text-dark); margin-bottom: 0.5rem;">Allogeneic Stem Cells</h4>
                    <p style="margin-bottom: 0; font-style: italic;">Are derived from genetically different individuals
                        and hence have the donors’ DNA and express the donors’ HLA molecules.</p>
                </div>

                <!-- Technical Deep Dive: Autologous AD-MSCs -->
                <div class="tech-deep-dive fade-in" style="margin-top: 5rem;">
                    <h3
                        style="color: var(--color-primary); margin-bottom: 2rem; text-transform: uppercase; border-bottom: 2px solid var(--color-secondary); padding-bottom: 0.5rem;">
                        Autologous Adult Adipose-Derived Stem Cells (AD-MSCs)</h3>
                    <div
                        style="background: white; padding: 2.5rem; border-radius: 12px; box-shadow: var(--shadow-soft);">
                        <ol style="list-style-type: decimal; padding-left: 1.5rem; color: var(--color-text-dark);">
                            <li style="margin-bottom: 1rem;"><strong>Biological source:</strong> Patient’s own fat
                                tissue (Donor-receiver one person)</li>
                            <li style="margin-bottom: 1rem;"><strong>Cell fitness/age effect:</strong> Cells as old as
                                the patient; diabetes, ischemia, chemo, or aging can impair cell potency</li>
                            <li style="margin-bottom: 1rem;"><strong>Procedure:</strong> Same-day procedure, minimal
                                manipulation, no expansion</li>
                            <li style="margin-bottom: 1rem;"><strong>Processing:</strong>
                                <ul style="list-style: disc; padding-left: 1.5rem; margin-top: 0.5rem;">
                                    <li>15–20 min. mini-liposuction under local anesthesia by the doctor</li>
                                    <li>60–120 min. mechanical shredding or brief enzymatic isolation, incubation,
                                        in-house laboratory</li>
                                </ul>
                            </li>
                            <li style="margin-bottom: 1rem;"><strong>Deployment:</strong> 10-15 min. Immediate
                                intra-lesional injection</li>
                            <li style="margin-bottom: 1rem;"><strong>Cell dose:</strong> 0.5–2 × 10⁶ nucleated SVF cells
                                / 100 mL fat</li>
                            <li style="margin-bottom: 1rem;"><strong>Minimal manipulation:</strong> Mechanical harvest,
                                isolation and deployment, (or very short collagenase digestion)</li>
                            <li style="margin-bottom: 1rem;"><strong>Regulatory category:</strong> Falls under the FDA
                                same-day tissue-tract exception and hospital exemption. Not as a licensed drug</li>
                            <li style="margin-bottom: 1rem;"><strong>Immunology:</strong> Self → no rejection, same DNA
                                code, no immunosuppressive drugs needed</li>
                            <li style="margin-bottom: 1rem;"><strong>Safety profile:</strong> Autologous SVFs are safest
                                immunologically, moderate surgical risks only (small scar, bruise, rare infection or
                                local anesthesia complication - bad taste!)</li>
                            <li style="margin-bottom: 1rem;"><strong>Cost:</strong>
                                <ul style="list-style: disc; padding-left: 1.5rem; margin-top: 0.5rem;">
                                    <li>High per-patient (operating room + disposables + labor, x1 patient)</li>
                                    <li>No pharma-scale overheads, often sufficient</li>
                                </ul>
                            </li>
                            <li style="margin-bottom: 1rem;"><strong>Repeat treatments:</strong> Fresh Cells. New
                                liposuction each cycle</li>
                            <li style="margin-bottom: 1rem;"><strong>Clinical Efficacy (MSC):</strong>
                                <ul style="list-style: disc; padding-left: 1.5rem; margin-top: 0.5rem;">
                                    <li>Knee OA: pain ↓, MRI cartilage fill at 6 month</li>
                                    <li>ED: IIEF score ↑ 5 points at 3 m in 30 % men</li>
                                    <li>Cardiac, osteoarthritis, diabetic ulcers show benefit</li>
                                    <li>Immunomodulation</li>
                                </ul>
                            </li>
                            <li style="margin-bottom: 1rem;"><strong>Clinical Efficacy (Oncology):</strong> In multiple
                                myeloma, a 2nd auto-SCT gave superior overall & progression-free survival</li>
                            <li style="margin-bottom: 1rem;"><strong>For hematological malignancies:</strong> The choice
                                is disease-specific: autologous stem cell therapy dominates Myeloma</li>
                            <li style="margin-bottom: 1rem;"><strong>Limitations:</strong> Cell number & potency fall
                                with age/ co-morbidities. Only local or low-dose systemic use</li>
                            <li style="margin-bottom: 1rem;"><strong>When to choose:</strong>
                                <ul style="list-style: disc; padding-left: 1.5rem; margin-top: 0.5rem;">
                                    <li>Regulations allow same-day cell and tissue use</li>
                                    <li>Patient accepts minor surgery - Informed Consent</li>
                                    <li>Single-joint or small-volume local lesion</li>
                                    <li>Absolute zero immune risk</li>
                                </ul>
                            </li>
                            <li style="margin-bottom: 1rem;"><strong>Clinical-grade availability:</strong> Limited by
                                patient’s health</li>
                        </ol>
                    </div>
                </div>

                <!-- MSCs CD MARKERS -->
                <div class="tech-deep-dive fade-in" style="margin-top: 5rem; margin-bottom: 4rem;">
                    <h3
                        style="color: var(--color-primary); margin-bottom: 2rem; text-transform: uppercase; border-bottom: 2px solid var(--color-secondary); padding-bottom: 0.5rem;">
                        MSCs CD MARKERS</h3>
                    <p style="margin-bottom: 2rem; color: var(--color-text-dark); font-weight: 500;">Autologous Adult
                        ADIPOSE-DERIVED MESENCHYMAL STEM CELLS (AD-MSCs)</p>
                    <p style="margin-bottom: 2rem;">These cells are routinely identified by the following core set of
                        positive and negative CD antigens. The table below summarizes passages 2–4, human sub-cutaneous
                        lipo-aspirates.</p>

                    <div
                        style="overflow-x: auto; background: white; border-radius: 12px; box-shadow: var(--shadow-soft);">
                        <table style="width: 100%; border-collapse: collapse; min-width: 600px; text-align: left;">
                            <thead>
                                <tr style="background: var(--color-primary); color: white;">
                                    <th style="padding: 1.2rem; border: 1px solid rgba(255,255,255,0.1);">Positive (≥ 90
                                        %)</th>
                                    <th style="padding: 1.2rem; border: 1px solid rgba(255,255,255,0.1);">Negative (≤ 2
                                        %)</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD29 (integrin β1)</td>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD31 (endothelial)</td>
                                </tr>
                                <tr style="background: #fcfcfc;">
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD44 (hyaluronate)</td>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD34 (hematopoietic)*</td>
                                </tr>
                                <tr>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD73 (ecto-5′-NT)</td>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD45 (pan-leukocyte)</td>
                                </tr>
                                <tr style="background: #fcfcfc;">
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD90 (Thy-1)</td>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD11b (myeloid)</td>
                                </tr>
                                <tr>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD105 (endoglin)</td>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD14 (monocyte)</td>
                                </tr>
                                <tr style="background: #fcfcfc;">
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD13 (aminopeptidase)</td>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD19 (B-cell)</td>
                                </tr>
                                <tr>
                                    <td style="padding: 1rem; border: 1px solid #eee;">CD166 (ALCAM)</td>
                                    <td style="padding: 1rem; border: 1px solid #eee;">HLA-DR (MHC-II)</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div
                        style="margin-top: 2rem; font-size: 0.95rem; color: var(--color-text-grey); background: #f9f9f9; padding: 1.5rem; border-radius: 8px;">
                        <p style="margin-bottom: 1rem;"><em>*CD34 is positive in the freshly isolated stromal vascular
                                fraction SVF and during the first 1–2 passages; expression is lost once the cells are
                                expanded to standard clinical passages, so most laboratories still list CD34 as a
                                negative marker for “cultured” AD-MSCs.</em></p>
                        <ul style="list-style: disc; padding-left: 1.5rem;">
                            <li style="margin-bottom: 0.5rem;">CD106 (VCAM-1) and CD271 (NGFR) are also absent on
                                classic AD-MSCs, distinguishing them from bone-marrow MSCs.</li>
                            <li>HLA-ABC (MHC-I) is present at low/intermediate levels, whereas HLA-DR (MHC-II) is
                                consistently negative, underpinning their low immunogenicity.</li>
                        </ul>
                    </div>
                </div>

            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer id="main-footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-brand">
                    <h2>Holland Stem Cells</h2>
                    <p>Leading the way in regenerative medicine and stem cell research. Committed to improving lives
                        through science.</p>
                    <div style="margin-top: 1.5rem; display: flex; gap: 1rem; font-size: 1.2rem;">
                        <a href="#"><i class="fa-brands fa-linkedin"></i></a>
                        <a href="#"><i class="fa-brands fa-twitter"></i></a>
                        <a href="#"><i class="fa-brands fa-facebook"></i></a>
                    </div>
                </div>
                <div class="footer-col">
                    <h4>Company</h4>
                    <ul>
                        <li><a href="https://hollandstemcells.netlify.app/about">About Us</a></li>
                        <li><a href="https://hollandstemcells.netlify.app/leadership">Leadership</a></li>
                        <li><a href="#">Careers</a></li>
                        <li><a href="https://hollandstemcells.netlify.app/news">News</a></li>
                    </ul>
                </div>
                <div class="footer-col">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="https://hollandstemcells.netlify.app/patient-guide">Patient Guide</a></li>
                        <li><a href="https://hollandstemcells.netlify.app/research">Research</a></li>
                        <li><a href="https://hollandstemcells.netlify.app/faq">FAQ</a></li>
                        <li><a href="https://hollandstemcells.netlify.app/privacy-policy">Privacy Policy</a></li>
                    </ul>

                </div>
                <div class="footer-col">
                    <h4>Contact</h4>
                    <ul>
                        <li><i class="fa-solid fa-location-dot"></i> San Diego, CA, USA</li>
                        <li><i class="fa-solid fa-envelope"></i> Hollandlimited@gmail.com</li>
                        <li><i class="fa-solid fa-envelope"></i> hollandlimited@icloud.com</li>
                        <li><i class="fa-solid fa-phone"></i> +1 (858) 257-9691</li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                &copy; 2026 Holland Stem Cells. All Rights Reserved. Disclaimer: These therapies are
                investigational.
            </div>
        </div>
    </footer>

    <!-- Footnote -->
    <div class="footnote-container">
        <hr class="footnote-line">

        <p class="footnote-text">
            P.O. Box 74 &nbsp;|&nbsp; Tel: +1 (858) 257-9601 &nbsp;|&nbsp; Tel: +31 62383 6105 &nbsp;|&nbsp;
            hollandlimited@gmail.com &nbsp;|&nbsp; hollandlimited@icloud.com<br>
            Bank of America (BOAUS3N) &nbsp;|&nbsp;
            6522 Ambrosia Drive, #5111, San Diego, CA 92124, U.S.A. &nbsp;|&nbsp;
            Holland Stem Cells
        </p>

        <hr class="footnote-line">
    </div>

    <!-- JS -->
    <script src="js/app.js"></script>
</body>

</html>